RXFP2 and Hypertension resistant to conventional therapy: Recently, SNPs near CASZ1, LSP1 and RXFP2 have been associated with resistant hypertension in a genome-wide association study of 14,756 patients from Iceland, the UK Biobank and eMERGE33.